| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class II receptor activity | 2.02e-09 | 11 | 33 | 4 | GO:0032395 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 1.06e-07 | 27 | 33 | 4 | GO:0023026 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 5.99e-07 | 41 | 33 | 4 | GO:0023023 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.24e-06 | 49 | 33 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | antigen binding | 1.41e-05 | 190 | 33 | 5 | GO:0003823 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.53e-04 | 165 | 33 | 4 | GO:0140375 | |
| GeneOntologyMolecularFunction | peptide binding | 1.79e-03 | 318 | 33 | 4 | GO:0042277 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 3.72e-03 | 55 | 33 | 2 | GO:0008146 | |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 8.57e-09 | 16 | 32 | 4 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 8.57e-09 | 16 | 32 | 4 | GO:0002503 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 2.80e-08 | 21 | 32 | 4 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 2.80e-08 | 21 | 32 | 4 | GO:0002501 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.66e-07 | 32 | 32 | 4 | GO:0019886 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 2.71e-07 | 36 | 32 | 4 | GO:0002495 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.39e-07 | 38 | 32 | 4 | GO:0002504 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 8.85e-07 | 48 | 32 | 4 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 1.91e-06 | 58 | 32 | 4 | GO:0019884 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 2.68e-06 | 144 | 32 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 4.77e-06 | 162 | 32 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 4.89e-06 | 290 | 32 | 6 | GO:0050870 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 5.66e-06 | 76 | 32 | 4 | GO:0048002 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 8.13e-06 | 317 | 32 | 6 | GO:1903039 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 2.39e-05 | 226 | 32 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 2.44e-05 | 385 | 32 | 6 | GO:0051251 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 2.59e-05 | 389 | 32 | 6 | GO:0022409 | |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | 2.94e-05 | 236 | 32 | 5 | GO:0042129 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 2.95e-05 | 398 | 32 | 6 | GO:0046651 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 3.29e-05 | 406 | 32 | 6 | GO:0032943 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 3.32e-05 | 242 | 32 | 5 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 3.32e-05 | 242 | 32 | 5 | GO:1903708 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 4.14e-05 | 423 | 32 | 6 | GO:0002696 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 5.20e-05 | 266 | 32 | 5 | GO:0045619 | |
| GeneOntologyBiologicalProcess | leukocyte proliferation | 5.49e-05 | 445 | 32 | 6 | GO:0070661 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 5.63e-05 | 447 | 32 | 6 | GO:1903037 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 5.77e-05 | 449 | 32 | 6 | GO:0050867 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 5.95e-05 | 49 | 32 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 6.13e-05 | 139 | 32 | 4 | GO:0019882 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 6.44e-05 | 458 | 32 | 6 | GO:0050863 | |
| GeneOntologyBiologicalProcess | response to type II interferon | 6.48e-05 | 141 | 32 | 4 | GO:0034341 | |
| GeneOntologyBiologicalProcess | T cell proliferation | 7.58e-05 | 288 | 32 | 5 | GO:0042098 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 7.97e-05 | 54 | 32 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 8.93e-05 | 486 | 32 | 6 | GO:0007159 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | 9.33e-05 | 301 | 32 | 5 | GO:0050670 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | 1.01e-04 | 306 | 32 | 5 | GO:0032944 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1.04e-04 | 10 | 32 | 2 | GO:0032829 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 1.37e-04 | 171 | 32 | 4 | GO:0050868 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | 1.48e-04 | 332 | 32 | 5 | GO:0070663 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell differentiation | 1.96e-04 | 73 | 32 | 3 | GO:0043370 | |
| GeneOntologyBiologicalProcess | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 2.10e-04 | 14 | 32 | 2 | GO:0002361 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 2.13e-04 | 192 | 32 | 4 | GO:1903038 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 2.32e-04 | 579 | 32 | 6 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 2.34e-04 | 580 | 32 | 6 | GO:0022407 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | 2.59e-04 | 845 | 32 | 7 | GO:0050778 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 2.83e-04 | 382 | 32 | 5 | GO:0030217 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 3.06e-04 | 211 | 32 | 4 | GO:0051250 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 3.18e-04 | 614 | 32 | 6 | GO:0051249 | |
| GeneOntologyBiologicalProcess | T-helper cell differentiation | 3.88e-04 | 92 | 32 | 3 | GO:0042093 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell differentiation | 4.00e-04 | 93 | 32 | 3 | GO:0046637 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation involved in immune response | 4.13e-04 | 94 | 32 | 3 | GO:0002294 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation involved in immune response | 4.26e-04 | 95 | 32 | 3 | GO:0002293 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation involved in immune response | 4.67e-04 | 98 | 32 | 3 | GO:0002287 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 4.82e-04 | 429 | 32 | 5 | GO:1902105 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell activation | 4.95e-04 | 100 | 32 | 3 | GO:2000514 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 4.98e-04 | 240 | 32 | 4 | GO:0002695 | |
| GeneOntologyBiologicalProcess | T cell differentiation involved in immune response | 5.40e-04 | 103 | 32 | 3 | GO:0002292 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 5.98e-04 | 252 | 32 | 4 | GO:0022408 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 6.03e-04 | 107 | 32 | 3 | GO:0042130 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 6.09e-04 | 694 | 32 | 6 | GO:0002694 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | 6.18e-04 | 976 | 32 | 7 | GO:0046649 | |
| GeneOntologyBiologicalProcess | T cell activation | 6.42e-04 | 701 | 32 | 6 | GO:0042110 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 7.11e-04 | 264 | 32 | 4 | GO:0050866 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation | 8.22e-04 | 119 | 32 | 3 | GO:0043367 | |
| GeneOntologyBiologicalProcess | cell activation | 8.67e-04 | 1356 | 32 | 8 | GO:0001775 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 9.26e-04 | 124 | 32 | 3 | GO:0050672 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | 9.53e-04 | 756 | 32 | 6 | GO:0050865 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 9.70e-04 | 126 | 32 | 3 | GO:0032945 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 1.05e-03 | 31 | 32 | 2 | GO:0045591 | |
| GeneOntologyBiologicalProcess | regulation of immune response | 1.16e-03 | 1085 | 32 | 7 | GO:0050776 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 1.16e-03 | 134 | 32 | 3 | GO:0070664 | |
| GeneOntologyBiologicalProcess | innate immune response | 1.20e-03 | 1092 | 32 | 7 | GO:0045087 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 1.32e-03 | 537 | 32 | 5 | GO:0030098 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell activation | 1.34e-03 | 141 | 32 | 3 | GO:0046634 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 1.35e-03 | 540 | 32 | 5 | GO:1903706 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 1.54e-03 | 148 | 32 | 3 | GO:0002286 | |
| GeneOntologyBiologicalProcess | adaptive immune response | 1.62e-03 | 838 | 32 | 6 | GO:0002250 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell activation | 1.70e-03 | 153 | 32 | 3 | GO:0035710 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation | 1.82e-03 | 157 | 32 | 3 | GO:0046632 | |
| GeneOntologyBiologicalProcess | leukocyte activation | 1.93e-03 | 1186 | 32 | 7 | GO:0045321 | |
| GeneOntologyBiologicalProcess | positive regulation of CD4-positive, alpha-beta T cell differentiation | 2.21e-03 | 45 | 32 | 2 | GO:0043372 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 2.38e-03 | 614 | 32 | 5 | GO:0010720 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | 2.51e-03 | 1242 | 32 | 7 | GO:0002684 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 2.59e-03 | 375 | 32 | 4 | GO:0007162 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 2.69e-03 | 927 | 32 | 6 | GO:0030155 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 2.85e-03 | 640 | 32 | 5 | GO:1903131 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | 3.06e-03 | 1286 | 32 | 7 | GO:0140546 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 1.54e-08 | 17 | 35 | 4 | GO:0042613 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.59e-08 | 48 | 35 | 5 | GO:0098576 | |
| GeneOntologyCellularComponent | MHC protein complex | 9.59e-08 | 26 | 35 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.32e-07 | 35 | 35 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 3.90e-06 | 64 | 35 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 9.05e-06 | 79 | 35 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 2.40e-05 | 101 | 35 | 4 | GO:0045334 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 3.35e-05 | 110 | 35 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 3.60e-05 | 112 | 35 | 4 | GO:0032588 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 4.42e-05 | 237 | 35 | 5 | GO:0030136 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.04e-04 | 147 | 35 | 4 | GO:0030665 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.20e-04 | 293 | 35 | 5 | GO:0030658 | |
| GeneOntologyCellularComponent | trans-Golgi network | 1.47e-04 | 306 | 35 | 5 | GO:0005802 | |
| GeneOntologyCellularComponent | late endosome membrane | 2.21e-04 | 179 | 35 | 4 | GO:0031902 | |
| GeneOntologyCellularComponent | coated vesicle | 3.13e-04 | 360 | 35 | 5 | GO:0030135 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.21e-04 | 212 | 35 | 4 | GO:0030666 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 4.44e-04 | 215 | 35 | 4 | GO:0030662 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 8.03e-04 | 443 | 35 | 5 | GO:0098791 | |
| GeneOntologyCellularComponent | Golgi membrane | 1.14e-03 | 721 | 35 | 6 | GO:0000139 | |
| GeneOntologyCellularComponent | transport vesicle | 1.62e-03 | 519 | 35 | 5 | GO:0030133 | |
| GeneOntologyCellularComponent | late endosome | 2.63e-03 | 348 | 35 | 4 | GO:0005770 | |
| GeneOntologyCellularComponent | endosome membrane | 3.09e-03 | 602 | 35 | 5 | GO:0010008 | |
| GeneOntologyCellularComponent | endocytic vesicle | 3.74e-03 | 384 | 35 | 4 | GO:0030139 | |
| GeneOntologyCellularComponent | lysosomal membrane | 7.17e-03 | 462 | 35 | 4 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 7.17e-03 | 462 | 35 | 4 | GO:0098852 | |
| GeneOntologyCellularComponent | vacuolar membrane | 9.88e-03 | 507 | 35 | 4 | GO:0005774 | |
| GeneOntologyCellularComponent | lysosome | 1.07e-02 | 811 | 35 | 5 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 1.07e-02 | 811 | 35 | 5 | GO:0000323 | |
| GeneOntologyCellularComponent | side of membrane | 1.45e-02 | 875 | 35 | 5 | GO:0098552 | |
| Domain | C1-set_C | 5.16e-11 | 5 | 35 | 4 | PF16196 | |
| Domain | C1-set_C | 5.16e-11 | 5 | 35 | 4 | IPR032431 | |
| Domain | MHC_II_alpha | 5.16e-11 | 5 | 35 | 4 | SM00920 | |
| Domain | MHC_II_alpha | 1.55e-10 | 6 | 35 | 4 | PF00993 | |
| Domain | MHC_II_a_N | 3.60e-10 | 7 | 35 | 4 | IPR001003 | |
| Domain | MHC_II_a/b_N | 1.02e-08 | 14 | 35 | 4 | IPR014745 | |
| Domain | - | 1.02e-08 | 14 | 35 | 4 | 3.10.320.10 | |
| Domain | MHC_I/II-like_Ag-recog | 7.29e-07 | 38 | 35 | 4 | IPR011162 | |
| Domain | C1-set | 3.06e-06 | 54 | 35 | 4 | PF07654 | |
| Domain | IGc1 | 3.54e-06 | 56 | 35 | 4 | SM00407 | |
| Domain | Ig_C1-set | 4.08e-06 | 58 | 35 | 4 | IPR003597 | |
| Domain | Ig/MHC_CS | 4.08e-06 | 58 | 35 | 4 | IPR003006 | |
| Domain | IG_MHC | 4.68e-06 | 60 | 35 | 4 | PS00290 | |
| Domain | TLV_coat | 7.12e-05 | 7 | 35 | 2 | PF00429 | |
| Domain | TLV/ENV_coat_polyprotein | 9.49e-05 | 8 | 35 | 2 | IPR018154 | |
| Domain | DUF4599 | 2.23e-04 | 12 | 35 | 2 | PF15371 | |
| Domain | DUF4599 | 2.23e-04 | 12 | 35 | 2 | IPR027970 | |
| Domain | - | 1.11e-02 | 248 | 35 | 3 | 1.25.40.20 | |
| Domain | ANK | 1.14e-02 | 251 | 35 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 1.17e-02 | 253 | 35 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.18e-02 | 254 | 35 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.18e-02 | 254 | 35 | 3 | PS50297 | |
| Domain | TRYPSIN_SER | 1.23e-02 | 90 | 35 | 2 | IPR033116 | |
| Domain | Ankyrin_rpt | 1.28e-02 | 262 | 35 | 3 | IPR002110 | |
| Domain | IG_LIKE | 1.30e-02 | 491 | 35 | 4 | PS50835 | |
| Domain | Ig-like_dom | 1.41e-02 | 503 | 35 | 4 | IPR007110 | |
| Domain | TRYPSIN_HIS | 1.59e-02 | 103 | 35 | 2 | IPR018114 | |
| Domain | TRYPSIN_SER | 1.68e-02 | 106 | 35 | 2 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.71e-02 | 107 | 35 | 2 | PS00134 | |
| Domain | Peptidase_S1A | 1.90e-02 | 113 | 35 | 2 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.96e-02 | 115 | 35 | 2 | PS50240 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 4.91e-09 | 15 | 21 | 4 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 4.91e-09 | 15 | 21 | 4 | M47604 | |
| Pathway | KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 7.22e-09 | 48 | 21 | 5 | M615 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 5.76e-08 | 72 | 21 | 5 | M3126 | |
| Pathway | REACTOME_PD_1_SIGNALING | 7.28e-08 | 28 | 21 | 4 | M18810 | |
| Pathway | KEGG_ASTHMA | 9.72e-08 | 30 | 21 | 4 | M13950 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 1.68e-07 | 89 | 21 | 5 | M39398 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 2.33e-07 | 37 | 21 | 4 | M18615 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 2.73e-07 | 98 | 21 | 5 | M965 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 2.89e-07 | 39 | 21 | 4 | M16523 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 3.56e-07 | 41 | 21 | 4 | M13519 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 4.32e-07 | 43 | 21 | 4 | M12617 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 9.40e-07 | 52 | 21 | 4 | M13103 | |
| Pathway | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | 1.58e-06 | 16 | 21 | 3 | MM14808 | |
| Pathway | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | 2.72e-06 | 19 | 21 | 3 | MM14807 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 3.13e-06 | 70 | 21 | 4 | M12294 | |
| Pathway | REACTOME_PD_1_SIGNALING | 3.20e-06 | 20 | 21 | 3 | MM15001 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 3.91e-06 | 74 | 21 | 4 | M17386 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 7.82e-06 | 88 | 21 | 4 | M16004 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 8.14e-06 | 27 | 21 | 3 | MM14809 | |
| Pathway | PID_IL12_STAT4_PATHWAY | 1.37e-05 | 32 | 21 | 3 | M290 | |
| Pathway | REACTOME_TCR_SIGNALING | 3.04e-05 | 124 | 21 | 4 | M15381 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 3.24e-05 | 126 | 21 | 4 | M705 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 3.55e-05 | 129 | 21 | 4 | M39693 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 4.00e-05 | 133 | 21 | 4 | M16476 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 4.14e-05 | 273 | 21 | 5 | M983 | |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | 4.76e-05 | 139 | 21 | 4 | M4741 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 1.23e-04 | 66 | 21 | 3 | MM14990 | |
| Pathway | REACTOME_DOWNSTREAM_TCR_SIGNALING | 3.39e-04 | 93 | 21 | 3 | MM14806 | |
| Pathway | REACTOME_TCR_SIGNALING | 5.70e-04 | 111 | 21 | 3 | MM14803 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 6.48e-04 | 116 | 21 | 3 | MM14855 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 6.72e-04 | 26 | 21 | 2 | M39711 | |
| Pathway | WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT | 6.72e-04 | 26 | 21 | 2 | M46461 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 7.92e-04 | 789 | 21 | 6 | M1060 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 8.38e-04 | 29 | 21 | 2 | M6910 | |
| Pathway | WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION | 2.10e-03 | 46 | 21 | 2 | M39901 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 2.48e-03 | 185 | 21 | 3 | M39718 | |
| Pathway | PID_TELOMERASE_PATHWAY | 4.41e-03 | 67 | 21 | 2 | M105 | |
| Pubmed | HIV-1 Nef impairs MHC class II antigen presentation and surface expression. | 4.23e-10 | 12 | 35 | 4 | 11593029 | |
| Pubmed | 4.23e-10 | 12 | 35 | 4 | 12970439 | ||
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 8.54e-10 | 14 | 35 | 4 | 7512597 | |
| Pubmed | Epistatic suppression of systemic lupus erythematosus: fine mapping of Sles1 to less than 1 mb. | 8.54e-10 | 14 | 35 | 4 | 16002707 | |
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 8.54e-10 | 14 | 35 | 4 | 1869305 | |
| Pubmed | The murine Ia alpha chains, E alpha and A alpha, show a surprising degree of sequence homology. | 9.34e-10 | 3 | 35 | 3 | 6300851 | |
| Pubmed | Isotypic and allotypic variation of human class II histocompatibility antigen alpha-chain genes. | 9.34e-10 | 3 | 35 | 3 | 6584734 | |
| Pubmed | The class II molecules of the human and murine major histocompatibility complex. | 9.34e-10 | 3 | 35 | 3 | 6198089 | |
| Pubmed | Life-span, T-cell responses, and incidence of lymphomas in congenic mice. | 9.34e-10 | 3 | 35 | 3 | 7732019 | |
| Pubmed | 1.16e-09 | 15 | 35 | 4 | 8376762 | ||
| Pubmed | 1.16e-09 | 15 | 35 | 4 | 8168144 | ||
| Pubmed | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. | 1.16e-09 | 15 | 35 | 4 | 22860026 | |
| Pubmed | 1.16e-09 | 15 | 35 | 4 | 7602119 | ||
| Pubmed | 1.16e-09 | 15 | 35 | 4 | 1967269 | ||
| Pubmed | 1.16e-09 | 15 | 35 | 4 | 9079699 | ||
| Pubmed | 1.16e-09 | 15 | 35 | 4 | 3489470 | ||
| Pubmed | 1.16e-09 | 15 | 35 | 4 | 10729169 | ||
| Pubmed | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | 1.55e-09 | 16 | 35 | 4 | 2846691 | |
| Pubmed | 1.55e-09 | 16 | 35 | 4 | 1978941 | ||
| Pubmed | Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. | 1.55e-09 | 16 | 35 | 4 | 2543930 | |
| Pubmed | 1.55e-09 | 16 | 35 | 4 | 17959659 | ||
| Pubmed | 2.03e-09 | 17 | 35 | 4 | 15194762 | ||
| Pubmed | 2.03e-09 | 17 | 35 | 4 | 24904546 | ||
| Pubmed | HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. | 2.60e-09 | 18 | 35 | 4 | 19620308 | |
| Pubmed | 2.60e-09 | 18 | 35 | 4 | 11118314 | ||
| Pubmed | 2.60e-09 | 18 | 35 | 4 | 10661406 | ||
| Pubmed | Molecular analysis of the pathogenesis of autoimmune insulitis in NOD mice. | 3.73e-09 | 4 | 35 | 3 | 7809906 | |
| Pubmed | MHC characterization of ALR and ALS mice: respective similarities to the NOD and NON strains. | 3.73e-09 | 4 | 35 | 3 | 10369935 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 47219 | ||
| Pubmed | Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice. | 3.73e-09 | 4 | 35 | 3 | 10072504 | |
| Pubmed | Nef performance in macrophages: the master orchestrator of viral persistence and spread. | 4.11e-09 | 20 | 35 | 4 | 22103834 | |
| Pubmed | 4.11e-09 | 20 | 35 | 4 | 7541827 | ||
| Pubmed | 4.11e-09 | 20 | 35 | 4 | 12427289 | ||
| Pubmed | 5.08e-09 | 21 | 35 | 4 | 21778700 | ||
| Pubmed | 5.08e-09 | 21 | 35 | 4 | 8084338 | ||
| Pubmed | 7.50e-09 | 23 | 35 | 4 | 19770068 | ||
| Pubmed | 9.00e-09 | 24 | 35 | 4 | 18945465 | ||
| Pubmed | Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. | 9.00e-09 | 24 | 35 | 4 | 15489916 | |
| Pubmed | Editorial. Nef: a notorious enigmatic factor in HIV biology. | 9.00e-09 | 24 | 35 | 4 | 22175768 | |
| Pubmed | Detection of a new cerebral malaria susceptibility locus, using CBA mice. | 9.32e-09 | 5 | 35 | 3 | 15536567 | |
| Pubmed | Immunochemical evidence for three Ia loci in the I-region of the H-2 complex. | 9.32e-09 | 5 | 35 | 3 | 72779 | |
| Pubmed | 1.07e-08 | 25 | 35 | 4 | 16091223 | ||
| Pubmed | 1.26e-08 | 26 | 35 | 4 | 11827988 | ||
| Pubmed | Interactions of viral protein U (Vpu) with cellular factors. | 1.48e-08 | 27 | 35 | 4 | 20012522 | |
| Pubmed | 1.48e-08 | 27 | 35 | 4 | 12836198 | ||
| Pubmed | Keeping the (kinase) party going: SLP-76 and ITK dance to the beat. | 1.73e-08 | 28 | 35 | 4 | 17652306 | |
| Pubmed | One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef. | 1.73e-08 | 28 | 35 | 4 | 22103833 | |
| Pubmed | Absence of MHC class II expression distinguishes fetal from adult B lymphopoiesis in mice. | 1.86e-08 | 6 | 35 | 3 | 8176204 | |
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 1953819 | ||
| Pubmed | Assembly of major histocompatibility complex class II subunits with invariant chain. | 1.86e-08 | 6 | 35 | 3 | 16242130 | |
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 10468609 | ||
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 7679955 | ||
| Pubmed | The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. | 1.86e-08 | 6 | 35 | 3 | 3003909 | |
| Pubmed | 2.00e-08 | 29 | 35 | 4 | 15078178 | ||
| Pubmed | 2.31e-08 | 30 | 35 | 4 | 16454711 | ||
| Pubmed | Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence. | 2.65e-08 | 31 | 35 | 4 | 21922073 | |
| Pubmed | 2.65e-08 | 31 | 35 | 4 | 11048639 | ||
| Pubmed | 3.03e-08 | 32 | 35 | 4 | 19449444 | ||
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 6290895 | ||
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 11714799 | ||
| Pubmed | Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. | 3.44e-08 | 33 | 35 | 4 | 16354571 | |
| Pubmed | Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. | 5.66e-08 | 101 | 35 | 5 | 20587610 | |
| Pubmed | 1.11e-07 | 10 | 35 | 3 | 8102126 | ||
| Pubmed | Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy? | 1.49e-07 | 47 | 35 | 4 | 19149577 | |
| Pubmed | MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance? | 1.53e-07 | 11 | 35 | 3 | 11027433 | |
| Pubmed | 1.53e-07 | 11 | 35 | 3 | 23472185 | ||
| Pubmed | Extensive polymorphism surrounding the murine Ia A beta chain gene. | 2.65e-07 | 13 | 35 | 3 | 6311906 | |
| Pubmed | 3.37e-07 | 14 | 35 | 3 | 3860873 | ||
| Pubmed | Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies. | 4.21e-07 | 15 | 35 | 3 | 23349640 | |
| Pubmed | 6.29e-07 | 17 | 35 | 3 | 21779181 | ||
| Pubmed | Tracts of high or low sequence divergence in the mouse major histocompatibility complex. | 7.54e-07 | 18 | 35 | 3 | 6098460 | |
| Pubmed | 7.54e-07 | 18 | 35 | 3 | 18987644 | ||
| Pubmed | 7.54e-07 | 18 | 35 | 3 | 19116923 | ||
| Pubmed | 8.75e-07 | 175 | 35 | 5 | 19851445 | ||
| Pubmed | Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. | 8.95e-07 | 19 | 35 | 3 | 2576007 | |
| Pubmed | A molecular basis for the Ia.2 and Ia.19 antigenic determinants. | 9.84e-07 | 2 | 35 | 2 | 2581258 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 22105689 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 8879564 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11712854 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16322110 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12580031 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 1329933 | ||
| Pubmed | Evidence for more than one Parkinson's disease-associated variant within the HLA region. | 9.84e-07 | 2 | 35 | 2 | 22096524 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 3266023 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 7912458 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 3610256 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 6300884 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 38922958 | ||
| Pubmed | The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. | 9.84e-07 | 2 | 35 | 2 | 8543793 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18826608 | ||
| Pubmed | Human thymic epithelial cells express functional HLA-DP molecules. | 9.84e-07 | 2 | 35 | 2 | 8773319 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12707403 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9687536 | ||
| Pubmed | Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice. | 9.84e-07 | 2 | 35 | 2 | 17142726 | |
| Pubmed | Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. | 9.84e-07 | 2 | 35 | 2 | 8398989 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10384102 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 17947646 | ||
| Pubmed | Regions of allelic hypervariability in the murine A alpha immune response gene. | 9.84e-07 | 2 | 35 | 2 | 6309407 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 7722444 | ||
| Pubmed | Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression. | 9.84e-07 | 2 | 35 | 2 | 25252912 | |
| Interaction | HLA-DQB1 interactions | 7.37e-06 | 82 | 31 | 4 | int:HLA-DQB1 | |
| Interaction | DSE interactions | 1.74e-05 | 33 | 31 | 3 | int:DSE | |
| Interaction | HLA-DQA2 interactions | 3.42e-05 | 6 | 31 | 2 | int:HLA-DQA2 | |
| Interaction | SEMA6B interactions | 5.10e-05 | 47 | 31 | 3 | int:SEMA6B | |
| Interaction | FKTN interactions | 1.25e-04 | 11 | 31 | 2 | int:FKTN | |
| Interaction | SLC38A10 interactions | 1.35e-04 | 65 | 31 | 3 | int:SLC38A10 | |
| Interaction | HLA-DRB3 interactions | 1.48e-04 | 67 | 31 | 3 | int:HLA-DRB3 | |
| Interaction | OR5F1 interactions | 1.50e-04 | 12 | 31 | 2 | int:OR5F1 | |
| Cytoband | 6p21.3 | 1.31e-06 | 250 | 35 | 5 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 3.83e-05 | 503 | 35 | 5 | chr6p21 | |
| Cytoband | 9q21.32 | 9.58e-05 | 19 | 35 | 2 | 9q21.32 | |
| Cytoband | 20q11.23 | 3.70e-04 | 37 | 35 | 2 | 20q11.23 | |
| Cytoband | 19q13.41 | 1.64e-03 | 78 | 35 | 2 | 19q13.41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 4.79e-03 | 135 | 35 | 2 | chr8p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 1.01e-02 | 199 | 35 | 2 | chr9q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.25e-02 | 1192 | 35 | 4 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q11 | 1.54e-02 | 248 | 35 | 2 | chr20q11 | |
| GeneFamily | C1-set domain containing | 1.46e-07 | 42 | 21 | 4 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.77e-07 | 44 | 21 | 4 | 588 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.15e-03 | 181 | 21 | 3 | 694 | |
| GeneFamily | Ankyrin repeat domain containing | 2.64e-03 | 242 | 21 | 3 | 403 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MACROPHAGES | 5.18e-08 | 80 | 33 | 5 | M39282 | |
| Coexpression | HELLER_SILENCED_BY_METHYLATION_UP | 5.34e-08 | 283 | 33 | 7 | M8776 | |
| Coexpression | MCLACHLAN_DENTAL_CARIES_UP | 8.89e-07 | 265 | 33 | 6 | M10454 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 2.13e-06 | 73 | 33 | 4 | M11428 | |
| Coexpression | DESCARTES_FETAL_LUNG_MYELOID_CELLS | 2.78e-06 | 178 | 33 | 5 | M40244 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP | 3.57e-06 | 83 | 33 | 4 | M17951 | |
| Coexpression | GSE10325_CD4_TCELL_VS_BCELL_DN | 4.34e-06 | 195 | 33 | 5 | M3077 | |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN | 4.45e-06 | 196 | 33 | 5 | M3085 | |
| Coexpression | HAY_BONE_MARROW_DENDRITIC_CELL | 4.56e-06 | 197 | 33 | 5 | M39194 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_UP | 4.56e-06 | 197 | 33 | 5 | M9537 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN | 4.67e-06 | 198 | 33 | 5 | M4264 | |
| Coexpression | ZHENG_CORD_BLOOD_C6_HSC_MULTIPOTENT_PROGENITOR | 6.64e-06 | 97 | 33 | 4 | M39215 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 8.11e-06 | 102 | 33 | 4 | MM1064 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_MYELOID_CELLS | 9.67e-06 | 230 | 33 | 5 | M40210 | |
| Coexpression | VALK_AML_CLUSTER_6 | 1.06e-05 | 34 | 33 | 3 | M4965 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES | 1.49e-05 | 38 | 33 | 3 | M39297 | |
| Coexpression | BUSSLINGER_GASTRIC_REG3A_POSITIVE_CELLS | 2.32e-05 | 44 | 33 | 3 | M40016 | |
| Coexpression | DESCARTES_FETAL_HEART_MYELOID_CELLS | 2.52e-05 | 136 | 33 | 4 | M40196 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 2.67e-05 | 138 | 33 | 4 | MM1047 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_MYELOID_CELLS | 3.33e-05 | 146 | 33 | 4 | M40285 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | 3.38e-05 | 501 | 33 | 6 | M5389 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE | 5.92e-05 | 60 | 33 | 3 | M40971 | |
| Coexpression | AIZARANI_LIVER_C25_KUPFFER_CELLS_4 | 6.60e-05 | 174 | 33 | 4 | M39126 | |
| Coexpression | BEIER_GLIOMA_STEM_CELL_DN | 8.24e-05 | 67 | 33 | 3 | M11720 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_MYELOID_CELLS | 8.38e-05 | 185 | 33 | 4 | M40148 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_SMOOTH_MUSCLE_CELL_OF_THE_PULMONARY_ARTERY_AGEING | 8.39e-05 | 11 | 33 | 2 | MM3774 | |
| Coexpression | GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN | 9.86e-05 | 193 | 33 | 4 | M6150 | |
| Coexpression | GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP | 9.86e-05 | 193 | 33 | 4 | M6143 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_VEIN_ENDOTHELIAL_CELL_AGEING | 1.01e-04 | 12 | 33 | 2 | MM3776 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN | 1.03e-04 | 195 | 33 | 4 | M4279 | |
| Coexpression | GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP | 1.03e-04 | 195 | 33 | 4 | M9527 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 1.03e-04 | 195 | 33 | 4 | M7382 | |
| Coexpression | GSE360_DC_VS_MAC_T_GONDII_UP | 1.09e-04 | 198 | 33 | 4 | M5183 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN | 1.13e-04 | 200 | 33 | 4 | M8033 | |
| Coexpression | AIZARANI_LIVER_C2_KUPFFER_CELLS_1 | 1.13e-04 | 200 | 33 | 4 | M39106 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP | 1.13e-04 | 200 | 33 | 4 | M9208 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 1.15e-04 | 75 | 33 | 3 | MM3718 | |
| Coexpression | DESCARTES_FETAL_STOMACH_MYELOID_CELLS | 1.20e-04 | 76 | 33 | 3 | M40302 | |
| Coexpression | TRAVAGLINI_LUNG_MESOTHELIAL_CELL | 1.41e-04 | 649 | 33 | 6 | M41679 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 1.73e-04 | 86 | 33 | 3 | M2259 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 1.82e-04 | 16 | 33 | 2 | MM3766 | |
| Coexpression | AIZARANI_LIVER_C6_KUPFFER_CELLS_2 | 1.87e-04 | 228 | 33 | 4 | M39110 | |
| Coexpression | JIANG_MELANOMA_TRM10_LAMINA_PROPRIA | 2.05e-04 | 91 | 33 | 3 | M48974 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 2.05e-04 | 91 | 33 | 3 | MM3720 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | 2.22e-04 | 1012 | 33 | 7 | M40868 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 2.55e-04 | 98 | 33 | 3 | MM460 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 2.59e-04 | 19 | 33 | 2 | MM797 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 2.71e-04 | 100 | 33 | 3 | MM458 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_B_CELL | 2.79e-04 | 101 | 33 | 3 | M39045 | |
| Coexpression | UNTERMAN_IPF_VS_CTRL_MONOCYTE_DN | 2.88e-04 | 20 | 33 | 2 | M48278 | |
| Coexpression | LUI_THYROID_CANCER_CLUSTER_4 | 3.18e-04 | 21 | 33 | 2 | M4333 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 3.18e-04 | 21 | 33 | 2 | M41167 | |
| Coexpression | YAN_ESCAPE_FROM_ANOIKIS | 3.83e-04 | 23 | 33 | 2 | M1221 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 4.08e-04 | 115 | 33 | 3 | M5487 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_UP | 4.17e-04 | 24 | 33 | 2 | M41045 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 4.17e-04 | 24 | 33 | 2 | MM3779 | |
| Coexpression | LENAOUR_DENDRITIC_CELL_MATURATION_UP | 4.18e-04 | 116 | 33 | 3 | M4562 | |
| Coexpression | WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN | 4.53e-04 | 25 | 33 | 2 | M18519 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP | 4.53e-04 | 25 | 33 | 2 | M18122 | |
| Coexpression | AIZARANI_LIVER_C18_NK_NKT_CELLS_5 | 4.73e-04 | 121 | 33 | 3 | M39120 | |
| Coexpression | TRAVAGLINI_LUNG_MUCOUS_CELL | 5.20e-04 | 125 | 33 | 3 | M41656 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_UP | 5.33e-04 | 126 | 33 | 3 | M16381 | |
| Coexpression | WALLACE_PROSTATE_CANCER_RACE_UP | 5.50e-04 | 303 | 33 | 4 | M10319 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP | 5.69e-04 | 28 | 33 | 2 | MM707 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_MYELOID_CELLS | 5.83e-04 | 130 | 33 | 3 | M40259 | |
| Coexpression | AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS | 6.37e-04 | 134 | 33 | 3 | M39133 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_DN | 6.94e-04 | 138 | 33 | 3 | MM1151 | |
| Coexpression | TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL | 6.96e-04 | 572 | 33 | 5 | M41698 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 6.99e-04 | 31 | 33 | 2 | MM3729 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL | 7.07e-04 | 324 | 33 | 4 | M39160 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_MYELOID | 7.09e-04 | 139 | 33 | 3 | M39044 | |
| Coexpression | TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL | 7.24e-04 | 577 | 33 | 5 | M41697 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 8.01e-04 | 145 | 33 | 3 | MM3744 | |
| Coexpression | JIANG_MELANOMA_TRM2_CD8 | 8.17e-04 | 146 | 33 | 3 | M48966 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_B_CELLS | 8.91e-04 | 35 | 33 | 2 | M39289 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 9.62e-04 | 352 | 33 | 4 | M17471 | |
| Coexpression | MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN | 1.05e-03 | 159 | 33 | 3 | M38979 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CI_MESENCHYMAL_CELLS | 1.06e-03 | 361 | 33 | 4 | M39166 | |
| Coexpression | GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP | 1.06e-03 | 160 | 33 | 3 | M339 | |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP | 1.11e-03 | 39 | 33 | 2 | M6984 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 1.11e-03 | 39 | 33 | 2 | MM3725 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE | 1.16e-03 | 40 | 33 | 2 | M41037 | |
| Coexpression | MA_RAT_AGING_DN | 1.27e-03 | 170 | 33 | 3 | MM16097 | |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE | 1.34e-03 | 43 | 33 | 2 | M41036 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | 1.39e-03 | 389 | 33 | 4 | M4995 | |
| Coexpression | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP | 1.41e-03 | 44 | 33 | 2 | MM806 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_B_CELLS | 1.42e-03 | 177 | 33 | 3 | M41753 | |
| Coexpression | GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN | 1.54e-03 | 46 | 33 | 2 | M11636 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_MYELOID_LEUKOCYTE_AGEING | 1.54e-03 | 46 | 33 | 2 | MM3755 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 1.54e-03 | 46 | 33 | 2 | MM3712 | |
| Coexpression | TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL | 1.61e-03 | 405 | 33 | 4 | M41667 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN | 1.72e-03 | 189 | 33 | 3 | M4261 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NON_CLASSICAL_MONOCYTE_AGEING | 1.74e-03 | 49 | 33 | 2 | MM3772 | |
| Coexpression | CYCLIN_D1_UP.V1_DN | 1.74e-03 | 190 | 33 | 3 | M2652 | |
| Coexpression | GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP | 1.74e-03 | 190 | 33 | 3 | M4684 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN | 1.80e-03 | 192 | 33 | 3 | M4277 | |
| Coexpression | TSUNODA_CISPLATIN_RESISTANCE_DN | 1.81e-03 | 50 | 33 | 2 | M5014 | |
| Coexpression | RAF_UP.V1_DN | 1.82e-03 | 193 | 33 | 3 | M2726 | |
| Coexpression | FAN_OVARY_CL18_B_LYMPHOCYTE | 1.87e-03 | 422 | 33 | 4 | M41720 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN | 1.90e-03 | 196 | 33 | 3 | M4267 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.77e-05 | 95 | 35 | 4 | geo_heart_1000_K1 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.19e-05 | 44 | 35 | 3 | gudmap_kidney_adult_CortVasc_Tie2_k3_1000 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | 5.74e-05 | 850 | 35 | 8 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_500_k-means-cluster#1 | 7.18e-05 | 49 | 35 | 3 | geo_heart_500_K1 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#1_top-relative-expression-ranked_200 | 1.44e-04 | 11 | 35 | 2 | gudmap_kidney_adult_RenMedVasc_Tie2_k1_200 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#3_top-relative-expression-ranked_500 | 2.04e-04 | 13 | 35 | 2 | gudmap_kidney_adult_RenalCortexMixed_Std_k3_500 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.06e-04 | 334 | 35 | 5 | geo_heart_2500_K4 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | 3.44e-04 | 83 | 35 | 3 | GSM538263_100 | |
| CoexpressionAtlas | B cells, B.FrE.BM, CD19+ IgM+ AA4.1+ HSA+, Bone marrow, avg-3 | 3.55e-04 | 376 | 35 | 5 | GSM399438_500 | |
| CoexpressionAtlas | PP_HSC_top-relative-expression-ranked_500_k-means-cluster#5 | 3.76e-04 | 209 | 35 | 4 | PP_HSC_500_K5 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-1 | 3.95e-04 | 87 | 35 | 3 | GSM538262_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_200 | 4.92e-04 | 20 | 35 | 2 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_200 | |
| CoexpressionAtlas | PP_epoMEP_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.05e-04 | 406 | 35 | 5 | PP_epoMEP_1000_K4 | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.14e-09 | 183 | 35 | 6 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-09 | 186 | 35 | 6 | 75b1f342be5d6dbe0e7acd924a0ca75964f6bab0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-09 | 186 | 35 | 6 | 0c3d195077de7b4c354c127a26116438aef29244 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-09 | 186 | 35 | 6 | a558fd00053e7dd6216b01dc8e650c30cee451f1 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 8.70e-09 | 194 | 35 | 6 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.70e-09 | 194 | 35 | 6 | 1b4a17d58793e8889484fe592dce8ee1e8fe77a9 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 9.25e-09 | 196 | 35 | 6 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | Control-Myeloid-DC2|Myeloid / Condition, Lineage and Cell class | 9.53e-09 | 197 | 35 | 6 | e0ee15188ff0d9df3c3b5ea523553ce18d223c33 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.83e-09 | 198 | 35 | 6 | 1637a255b67527fc9f9eb5352fb81cda9168fdfb | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-B_cells|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.83e-09 | 198 | 35 | 6 | 3f8c24295ea98c9fbcad2dc5fee17851197e60b3 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.83e-09 | 198 | 35 | 6 | 232905d61002fc552e2a8920167dceb550e8eec6 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-B_cell-B_cell-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.83e-09 | 198 | 35 | 6 | b090c28336b4a0f9acab192885d9c2c2cc5d36e7 | |
| ToppCell | COVID-19_Mild-CD8+_Tem|COVID-19_Mild / Disease condition and Cell class | 1.01e-08 | 199 | 35 | 6 | 9016fbe5fe55e1ffa279ee8e8db3c93b5cf914d5 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-cDC-DCs|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-08 | 200 | 35 | 6 | 0576e34dc9a6adae5782659511d641781c6a44ed | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-08 | 200 | 35 | 6 | 337daee31dd5a277b9ef1dbd7fd6660371636084 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-cDC-DCs-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-08 | 200 | 35 | 6 | b074b30cd7bb893c24cd49af1b2126825c59eef7 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.04e-08 | 200 | 35 | 6 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-DCs|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.04e-08 | 200 | 35 | 6 | cae0e62804e41828e9cf74b9e3452c43a12bc87d | |
| ToppCell | Dendritic_Cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.51e-08 | 100 | 35 | 5 | bb7bd11e28be830f381144d4a6f29a86da59d9fa | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.34e-08 | 137 | 35 | 5 | 86c32cd26fe3b23c1dcd8ace580231c5a6ec6d9e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.34e-08 | 137 | 35 | 5 | 8989103606b15dff300e44c1590cd867b3cf7833 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.41e-08 | 144 | 35 | 5 | a4bb274d553c29c8299354de757ecc5634008c68 | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 1.19e-07 | 151 | 35 | 5 | 23b6cf9a36ad0e937f69c75921bddd305a9a526c | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-07 | 158 | 35 | 5 | f9cfb110342be3c91aba9914805332f22ba89101 | |
| ToppCell | Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, Lineage and Cell Type | 1.64e-07 | 161 | 35 | 5 | bcd122af09cbb99d1816200d9c367af8b7f36873 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 1.69e-07 | 162 | 35 | 5 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.85e-07 | 165 | 35 | 5 | 6b1c29dcef5a945786806ddbddddcec0023bd66e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-07 | 166 | 35 | 5 | d373f1092e85eeb317a7406032b259f11e6adbe0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-07 | 166 | 35 | 5 | f453a1d545d59003d98485ac31e85e6cf451817c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.15e-07 | 170 | 35 | 5 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-07 | 172 | 35 | 5 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-07 | 172 | 35 | 5 | 5fb0ea6145892a258696197b3feed9760187e712 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-07 | 172 | 35 | 5 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| ToppCell | 15-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 2.28e-07 | 172 | 35 | 5 | 36f2444754f1e37683cb812380e6b05b356f9f4a | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-07 | 172 | 35 | 5 | 07620728a6cdeea805e1365e588be096c17a370c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.35e-07 | 173 | 35 | 5 | 8384d533a1071fc65a06e6d9f5f17d8ab00c3966 | |
| ToppCell | Dendritic_Cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.35e-07 | 173 | 35 | 5 | ddb900ef4abeabe2e59db1009efc337e35d301fe | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.41e-07 | 174 | 35 | 5 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-07 | 175 | 35 | 5 | cddbd42c1cdfcdf2a41d96198ddb20e684ee6317 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue | 2.48e-07 | 175 | 35 | 5 | 1c48eec300d5a6d4a810947b995af3b8c0a5a601 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-07 | 175 | 35 | 5 | f5822cf48777880e670a6a18158ffb31d066c24a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-07 | 175 | 35 | 5 | 067f77c5d9ae3cf960b84ece80c25d5193873cbf | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD141+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 2.55e-07 | 176 | 35 | 5 | b9ba7026dee2272c0b483dc0cfa39f74b75f1634 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.63e-07 | 177 | 35 | 5 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | 390C-Lymphocytic-B_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-07 | 178 | 35 | 5 | 02cb514096435a4d8c84f0cc12ae627db319621d | |
| ToppCell | 390C-Lymphocytic-B_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-07 | 178 | 35 | 5 | 9af29e341087ba4dd3ef246cdbae6469ea9de15f | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|normal_Lung / Location, Cell class and cell subclass | 2.70e-07 | 178 | 35 | 5 | b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Brain / Location, Cell class and cell subclass | 2.86e-07 | 180 | 35 | 5 | 51727cb66fe7a7709453f7026e0ff3d6c93d5aa5 | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 2.86e-07 | 180 | 35 | 5 | 200cecbd8c12a4ec334583fdd5057397504de71e | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-07 | 181 | 35 | 5 | d1c69171600b2d2aec96fa86fa757b588c265f7c | |
| ToppCell | 11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 2.93e-07 | 181 | 35 | 5 | 193ee02f547a218b2fc13e1174ea4cff4f8a3450 | |
| ToppCell | ILEUM-non-inflamed-(3)_DC1|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.93e-07 | 181 | 35 | 5 | c9f53720249c8569598cc859e43e35c5f3f8475a | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|tumor_Lung / Location, Cell class and cell subclass | 3.02e-07 | 182 | 35 | 5 | 243779ba1009097f8fafa1a691e296ec3aeefc04 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-pre-pDC/DC5|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.02e-07 | 182 | 35 | 5 | fec8a2d6d4099722b8e1bb41222108ed74268fcf | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 3.02e-07 | 182 | 35 | 5 | 0ef8fb13488a65717b050b1b4e4bf062a1553eff | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | 3.10e-07 | 183 | 35 | 5 | c94ee9f35b21252e1ab5ab15b6a2ce69a7d753f7 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 3.10e-07 | 183 | 35 | 5 | f482e4fe011fa450a475034b1e25587233855bdb | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B-Naive_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 3.10e-07 | 183 | 35 | 5 | be294d22b91dbcf1e8d22e6a31c39b5caaad4751 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic|GI_small-bowel / Manually curated celltypes from each tissue | 3.10e-07 | 183 | 35 | 5 | 6109199cf25b28831193a5ed7925b5bf38c6eb43 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.18e-07 | 184 | 35 | 5 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 3.18e-07 | 184 | 35 | 5 | 8e393eea7240584a3cef718bee094e2705ec1891 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.18e-07 | 184 | 35 | 5 | 2dc4b2a9970111ed5e2977fc178595a12d7bb59d | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.18e-07 | 184 | 35 | 5 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.18e-07 | 184 | 35 | 5 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD141+_DCs|tumor_Lung / Location, Cell class and cell subclass | 3.18e-07 | 184 | 35 | 5 | f5cad8eb358898ae536cd7a7b37d3ce19528b801 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-07 | 185 | 35 | 5 | 7cf69717b88347833819c161ca89e751416f6c67 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.27e-07 | 185 | 35 | 5 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.27e-07 | 185 | 35 | 5 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.27e-07 | 185 | 35 | 5 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-07 | 185 | 35 | 5 | f1b555a0acc93c51e48fbe290f820ddc2c58e0d7 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.27e-07 | 185 | 35 | 5 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.27e-07 | 185 | 35 | 5 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Naive_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 3.27e-07 | 185 | 35 | 5 | 1c99373c123b5e0de40b47d9d885974a747b9839 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.27e-07 | 185 | 35 | 5 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-07 | 185 | 35 | 5 | 9542f9d77535ef0c66e9e3376bbbddba5bc1d463 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | 3.27e-07 | 185 | 35 | 5 | f78be85dd6e443abb7af20f98ff351c1131ece4d | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.27e-07 | 185 | 35 | 5 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.27e-07 | 185 | 35 | 5 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | BLOOD--(2)_Naive_B_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.36e-07 | 186 | 35 | 5 | 2e55a3892459152fc4a3a7834ccbf5d71b65d29a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 3.36e-07 | 186 | 35 | 5 | a5c0bd4f6a7542f67d478dcdc0645ae6d927a395 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC2|Liver / Manually curated celltypes from each tissue | 3.36e-07 | 186 | 35 | 5 | 92ef569c8f864d3abaa087cd3ce0366e8f9f50c2 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-07 | 186 | 35 | 5 | 9e46b202d5bf442a269d99d5c4b60a7800d4611e | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-07 | 186 | 35 | 5 | 712e46d44701f3013a13813aa150ec188ca864bd | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / Disease condition and Cell class | 3.36e-07 | 186 | 35 | 5 | 728d81405fdcd137097433dd676b26519185e916 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-07 | 186 | 35 | 5 | 0c55248b4a9f9bcc32a7e94329aea80796fd4a38 | |
| ToppCell | (1)_B_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.36e-07 | 186 | 35 | 5 | fe0f8e99ca766e004c351835fdbc2dc888dceb62 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.36e-07 | 186 | 35 | 5 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | BLOOD--(2)_B_cell| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.36e-07 | 186 | 35 | 5 | d9f2cab7f9e7aa476d9bcf5d15896113e59e03f8 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-07 | 186 | 35 | 5 | 2d9fb731bcc5fbe587cd304d69b18bc9a19fa727 | |
| ToppCell | (1)_B_CD27neg|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.36e-07 | 186 | 35 | 5 | 646389147189760e9493c4f50f9583959ef0ee26 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 3.36e-07 | 186 | 35 | 5 | a0cc925af97e47efd0c9bc17c37963e8ad4e5b35 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-07 | 186 | 35 | 5 | 5d1d77825b85f80de20d7b91418820c6dbdab84a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-07 | 186 | 35 | 5 | 61b5300f2d9b02e4c850642e4cae3648af46772f | |
| ToppCell | URO-Lymphocyte-B-B_naive|URO / Disease, Lineage and Cell Type | 3.45e-07 | 187 | 35 | 5 | 9ed6a39aae7126ddbd01aec3376113b6b4517383 | |
| ToppCell | (1)_B_CD27pos|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.45e-07 | 187 | 35 | 5 | bb189942123eb03dd6505f1af8771dd7285bb8b9 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue | 3.45e-07 | 187 | 35 | 5 | ab9c9930341527122f26fe5544c5c4818d1fd1b5 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-07 | 188 | 35 | 5 | 649d27b2ef735b481ec0ed4f7a9b39aacc472a78 | |
| ToppCell | control-Myeloid-Resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.54e-07 | 188 | 35 | 5 | 9bcd6a83da912d136745d1abcb34b3735141048c | |
| ToppCell | (3)_DC_1|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.54e-07 | 188 | 35 | 5 | ee616d14e060385ee55e4cd5b60218e9374c6065 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.54e-07 | 188 | 35 | 5 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| Computational | Genes in the cancer module 171. | 1.34e-07 | 138 | 20 | 6 | MODULE_171 | |
| Computational | Genes in the cancer module 208. | 2.54e-06 | 124 | 20 | 5 | MODULE_208 | |
| Computational | Immune response and Ag processing and presentation. | 7.54e-05 | 126 | 20 | 4 | MODULE_345 | |
| Computational | Genes in the cancer module 292. | 1.01e-04 | 136 | 20 | 4 | MODULE_292 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.02e-04 | 50 | 20 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_MHC_II | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.02e-04 | 50 | 20 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.02e-04 | 50 | 20 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Computational | Genes in the cancer module 436. | 1.07e-04 | 138 | 20 | 4 | MODULE_436 | |
| Computational | Immune (humoral) and inflammatory response. | 3.51e-04 | 546 | 20 | 6 | MODULE_84 | |
| Computational | Thymus genes. | 2.71e-03 | 325 | 20 | 4 | MODULE_44 | |
| Computational | Whole blood genes. | 3.57e-03 | 581 | 20 | 5 | MODULE_45 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.67e-03 | 49 | 20 | 2 | GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CYTOTOXIC | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.67e-03 | 49 | 20 | 2 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CYTOTOXIC | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.82e-03 | 50 | 20 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_ALVEOLAR | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.82e-03 | 50 | 20 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.82e-03 | 50 | 20 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.82e-03 | 50 | 20 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_18_INTERFERON_MHC_II_2 | |
| Computational | Neighborhood of IL6ST | 4.60e-03 | 55 | 20 | 2 | GCM_IL6ST | |
| Computational | Genes in the cancer module 46. | 5.40e-03 | 394 | 20 | 4 | MODULE_46 | |
| Computational | Immune response. | 5.60e-03 | 398 | 20 | 4 | MODULE_75 | |
| Disease | chronic hepatitis B virus infection | 1.04e-08 | 24 | 31 | 4 | EFO_0004239 | |
| Disease | asthma (is_implicated_in) | 1.36e-08 | 157 | 31 | 6 | DOID:2841 (is_implicated_in) | |
| Disease | onchocerciasis (is_implicated_in) | 1.07e-06 | 2 | 31 | 2 | DOID:11678 (is_implicated_in) | |
| Disease | susceptibility to plantar warts measurement | 2.39e-06 | 90 | 31 | 4 | EFO_0008406 | |
| Disease | membranous glomerulonephritis (is_implicated_in) | 3.20e-06 | 3 | 31 | 2 | DOID:10976 (is_implicated_in) | |
| Disease | mosquito bite reaction itch intensity measurement | 1.00e-05 | 129 | 31 | 4 | EFO_0008377 | |
| Disease | human papilloma virus infection, oral cavity cancer | 1.17e-05 | 42 | 31 | 3 | EFO_0001668, EFO_0005570 | |
| Disease | systemic lupus erythematosus | 1.55e-05 | 799 | 31 | 7 | MONDO_0007915 | |
| Disease | extranodal nasal NK/T cell lymphoma | 1.60e-05 | 6 | 31 | 2 | MONDO_0019472 | |
| Disease | osteoarthritis, knee | 2.22e-05 | 158 | 31 | 4 | EFO_0004616 | |
| Disease | response to interferon-beta | 2.24e-05 | 7 | 31 | 2 | GO_0035456 | |
| Disease | childhood onset asthma | 2.41e-05 | 334 | 31 | 5 | MONDO_0005405 | |
| Disease | coronary artery disease | 2.41e-05 | 1194 | 31 | 8 | EFO_0001645 | |
| Disease | serum alanine aminotransferase measurement | 2.66e-05 | 869 | 31 | 7 | EFO_0004735 | |
| Disease | interleukin-21 measurement | 2.98e-05 | 8 | 31 | 2 | EFO_0801724 | |
| Disease | oligoclonal band measurement | 2.98e-05 | 8 | 31 | 2 | EFO_0005206 | |
| Disease | IGA glomerulonephritis | 3.12e-05 | 58 | 31 | 3 | EFO_0004194 | |
| Disease | Sjogren syndrome | 3.45e-05 | 60 | 31 | 3 | EFO_0000699 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 3.81e-05 | 62 | 31 | 3 | EFO_0004616, EFO_1000786 | |
| Disease | susceptibility to hepatitis B infection measurement | 4.19e-05 | 64 | 31 | 3 | EFO_0008405 | |
| Disease | MHC class I polypeptide-related sequence A measurement | 5.02e-05 | 68 | 31 | 3 | EFO_0008233 | |
| Disease | atopic asthma | 5.48e-05 | 199 | 31 | 4 | EFO_0010638 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 5.84e-05 | 11 | 31 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | factor VIII deficiency (is_implicated_in) | 5.84e-05 | 11 | 31 | 2 | DOID:12134 (is_implicated_in) | |
| Disease | uveitis (implicated_via_orthology) | 5.84e-05 | 11 | 31 | 2 | DOID:13141 (implicated_via_orthology) | |
| Disease | perceived unattractiveness to mosquitos measurement | 5.96e-05 | 72 | 31 | 3 | EFO_0008380 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 7.00e-05 | 12 | 31 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis | 8.27e-05 | 13 | 31 | 2 | EFO_0000685, EFO_0006527, EFO_0009459 | |
| Disease | aplastic anemia (is_implicated_in) | 8.27e-05 | 13 | 31 | 2 | DOID:12449 (is_implicated_in) | |
| Disease | nodular sclerosis Hodgkin lymphoma | 9.64e-05 | 14 | 31 | 2 | EFO_0004708 | |
| Disease | sickle cell anemia (is_marker_for) | 9.64e-05 | 14 | 31 | 2 | DOID:10923 (is_marker_for) | |
| Disease | oligoclonal band measurement, multiple sclerosis | 9.64e-05 | 14 | 31 | 2 | EFO_0005206, MONDO_0005301 | |
| Disease | systemic scleroderma | 9.78e-05 | 85 | 31 | 3 | EFO_0000717 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 9.78e-05 | 85 | 31 | 3 | DOID:9744 (is_implicated_in) | |
| Disease | liver neoplasm | 1.11e-04 | 15 | 31 | 2 | EFO_1001513 | |
| Disease | severe aplastic anemia | 1.11e-04 | 15 | 31 | 2 | EFO_0006927 | |
| Disease | allergic disease (is_implicated_in) | 1.11e-04 | 15 | 31 | 2 | DOID:1205 (is_implicated_in) | |
| Disease | pemphigus vulgaris | 1.27e-04 | 16 | 31 | 2 | EFO_0004719 | |
| Disease | gastroparesis | 1.27e-04 | 16 | 31 | 2 | EFO_1000948 | |
| Disease | anti-anoctamin 2 antibody measurement | 1.44e-04 | 17 | 31 | 2 | EFO_0010150 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 1.44e-04 | 17 | 31 | 2 | EFO_0010559, GO_0035456 | |
| Disease | allergic disease | 1.49e-04 | 258 | 31 | 4 | MONDO_0005271 | |
| Disease | tropical spastic paraparesis | 1.62e-04 | 18 | 31 | 2 | EFO_0007527 | |
| Disease | hepatitis B virus infection | 1.81e-04 | 19 | 31 | 2 | EFO_0004197 | |
| Disease | Oral ulcer | 1.94e-04 | 107 | 31 | 3 | HP_0000155 | |
| Disease | Henoch-Schoenlein purpura | 2.44e-04 | 22 | 31 | 2 | EFO_1000965 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 2.44e-04 | 22 | 31 | 2 | EFO_0021881 | |
| Disease | adult onset asthma | 2.58e-04 | 118 | 31 | 3 | EFO_1002011 | |
| Disease | response to vaccine | 2.85e-04 | 122 | 31 | 3 | EFO_0004645 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 2.91e-04 | 24 | 31 | 2 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | acne | 3.06e-04 | 125 | 31 | 3 | EFO_0003894 | |
| Disease | non-Hodgkins lymphoma | 3.16e-04 | 25 | 31 | 2 | EFO_0005952 | |
| Disease | complement C4b measurement | 3.16e-04 | 25 | 31 | 2 | EFO_0008092 | |
| Disease | primary biliary cirrhosis | 3.67e-04 | 133 | 31 | 3 | EFO_1001486 | |
| Disease | allergic rhinitis | 3.67e-04 | 133 | 31 | 3 | EFO_0005854 | |
| Disease | autism spectrum disorder, schizophrenia | 3.68e-04 | 327 | 31 | 4 | EFO_0003756, MONDO_0005090 | |
| Disease | ulcerative colitis | 4.03e-04 | 335 | 31 | 4 | EFO_0000729 | |
| Disease | Drugs affecting bone structure and mineralization use measurement | 4.26e-04 | 29 | 31 | 2 | EFO_0009936 | |
| Disease | grip strength measurement | 4.75e-04 | 350 | 31 | 4 | EFO_0006941 | |
| Disease | Takayasu arteritis | 5.01e-04 | 148 | 31 | 3 | EFO_1001857 | |
| Disease | fibrinogen measurement, coronary artery disease | 5.63e-04 | 154 | 31 | 3 | EFO_0001645, EFO_0004623 | |
| Disease | bullous pemphigoid | 5.87e-04 | 34 | 31 | 2 | EFO_0007187 | |
| Disease | psoriasis (is_implicated_in) | 5.87e-04 | 34 | 31 | 2 | DOID:8893 (is_implicated_in) | |
| Disease | lung disease (biomarker_via_orthology) | 6.22e-04 | 35 | 31 | 2 | DOID:850 (biomarker_via_orthology) | |
| Disease | multiple myeloma (is_marker_for) | 6.58e-04 | 36 | 31 | 2 | DOID:9538 (is_marker_for) | |
| Disease | hepatitis B (is_implicated_in) | 6.95e-04 | 37 | 31 | 2 | DOID:2043 (is_implicated_in) | |
| Disease | myositis | 7.73e-04 | 39 | 31 | 2 | EFO_0000783 | |
| Disease | lung adenocarcinoma | 8.02e-04 | 174 | 31 | 3 | EFO_0000571 | |
| Disease | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | 8.13e-04 | 40 | 31 | 2 | EFO_1001999, EFO_1002019, EFO_1002020 | |
| Disease | osteoarthritis, knee, body mass index | 8.54e-04 | 41 | 31 | 2 | EFO_0004340, EFO_0004616 | |
| Disease | urinary albumin to creatinine ratio | 8.71e-04 | 179 | 31 | 3 | EFO_0007778 | |
| Disease | Proteinuria | 9.39e-04 | 43 | 31 | 2 | C0033687 | |
| Disease | liver cirrhosis (is_implicated_in) | 9.39e-04 | 43 | 31 | 2 | DOID:5082 (is_implicated_in) | |
| Disease | biliary liver cirrhosis | 9.83e-04 | 44 | 31 | 2 | EFO_0004267 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKFDDHWVFWIGPLV | 196 | P41181 | |
| VEHWGLDQPLLKHWE | 196 | P20036 | |
| GWKSQLHKWFDSHIP | 231 | B6SEH9 | |
| WEDHHEEPGWDFEKG | 466 | Q8IWY9 | |
| EHWGLDKPLLKHWEP | 191 | P01909 | |
| IPWKHAAKHGWDINK | 36 | P10914 | |
| VWEHRKGTDYHKQPW | 481 | P00751 | |
| VEHWGLDEPLLKHWE | 191 | P01906 | |
| DPDIWHVGFKISWDI | 266 | Q9C0B1 | |
| GKFWAHEHWGLDDPA | 336 | P80404 | |
| GWKSQLHKWFDSHIP | 231 | B6SEH8 | |
| NEDLIKHGWPEDIWF | 26 | Q86WR0 | |
| KHGWPEDIWFHVDKL | 31 | Q86WR0 | |
| DVKDWDGWEPLHAAA | 256 | Q96T49 | |
| KVPVEQLRFWKHWHS | 291 | Q8TE85 | |
| EWGPQHFWHDVKLRF | 166 | Q5JPI3 | |
| AEELWKWKELGHDLH | 2931 | Q5VT06 | |
| EHWGLDEPLLKHWEF | 191 | P01903 | |
| GHKHVPDWVWIVVGI | 81 | Q9C0D9 | |
| VRLGEHHLWKWEGPE | 71 | Q9UKQ9 | |
| HHLWKWEGPEQLFRV | 76 | Q9UKQ9 | |
| WWHFKDHEEQDKVRP | 146 | O75586 | |
| THPVFFWLKHKLSGW | 126 | P59551 | |
| PFWASKGKLEWQHIH | 466 | Q6ZUB0 | |
| LHAWPKRLTKAHWFE | 21 | Q93091 | |
| TAHWKHPIFSFWDKK | 51 | Q96M20 | |
| HPEVKFSAIKEPHWW | 276 | Q7LFX5 | |
| EKQHIWHIPGLWHGA | 871 | Q8TCY9 | |
| PFWASKGKLEWQHIH | 466 | P0C874 | |
| PHWGTLEHWDVNKRD | 211 | P60852 | |
| DPEFWDWKTLKRHCH | 466 | Q13129 | |
| LGWKWIHEPKGYHAN | 306 | P01137 | |
| VWVWVMGEHHLDKPY | 76 | Q9H788 | |
| EIQEHGPEHWFSKWE | 11 | Q14CZ0 | |
| WVNWKDIHIKPEHYS | 161 | Q8TBZ6 | |
| AHAHWKGKEWPEFVR | 441 | Q2TBF2 | |
| ENHLFRWLMDHKPEW | 216 | O15050 | |
| EKWHEETGLKPPWHL | 406 | Q6BDS2 | |
| WTPLHAAAHWGVKEA | 251 | O60237 |